Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
CALL
Etsy
ETSY
$7.75B
| $49K | ﹤0.01% |
4,600
-83,700
| -95% | -$981K |
|
5252
German American Bancorp
GABC
$1.91B
| $49K | ﹤0.01% |
1,568
+911
| +139% | +$29.3K |
|
5253
Independent Bank Corp
IBCP
$787M
| $49K | ﹤0.01% |
+2,336
| New | +$49.4K |
|
5254
Ingles Markets
IMKTA
$1.71B
| $49K | ﹤0.01% |
1,136
-865
| -43% | -$39.8K |
|
5255
CALL
ITT
ITT
$17.5B
| $49K | ﹤0.01% |
1,200
-200
| -14% | -$8.22K |
|
5256
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $49K | ﹤0.01% |
1,260
| – | – |
|
5257
CALL
UBS Group
UBS
$173B
| $49K | ﹤0.01% |
3,100
-1,600
| -34% | -$25.8K |
|
|
WCC
5258
PUT
WESCO International
WCC
$16.7B
| $49K | ﹤0.01% |
700
-300
| -30% | -$21K |
|
5259
Willis Lease Finance
WLFC
$1.7B
| $49K | ﹤0.01% |
+6,654
| New | +$56.1K |
|
|
MN
5260
DELISTED
MANNING & NAPIER, INC.
MN
| $49K | ﹤0.01% |
8,580
+8,306
| +3,031% | +$54.7K |
|
|
CARO
5261
DELISTED
Carolina Financial Corp.
CARO
| $49K | ﹤0.01% |
1,637
-464
| -22% | -$14K |
|
|
XOXO
5262
DELISTED
Xo Group Inc
XOXO
| $49K | ﹤0.01% |
2,856
+2,504
| +711% | +$45.7K |
|
|
CHFN
5263
DELISTED
Charter Financial Corp
CHFN
| $49K | ﹤0.01% |
2,522
+2,254
| +841% | +$40.6K |
|
|
CSR
5264
Centerspace
CSR
$921M
| $48K | ﹤0.01% |
803
-307
| -28% | -$19.7K |
|
5265
Dorman Products
DORM
$3.98B
| $48K | ﹤0.01% |
580
-20,673
| -97% | -$1.53M |
|
5266
PUT
Eldorado Gold
EGO
$7.87B
| $48K | ﹤0.01% |
2,840
+40
| +1% | +$671 |
|
5267
PUT
iShares MSCI Canada ETF
EWC
$6.13B
| $48K | ﹤0.01% |
1,800
-5,900
| -77% | -$159K |
|
5268
CALL
Neurocrine Biosciences
NBIX
$16.8B
| $48K | ﹤0.01% |
1,100
-149,200
| -99% | -$6.39M |
|
5269
NovoCure
NVCR
$1.73B
| $48K | ﹤0.01% |
5,983
-55,596
| -90% | -$401K |
|
5270
CALL
Open Text
OTEX
$6.15B
| $48K | ﹤0.01% |
+1,400
| New | +$46.5K |
|
|
PLG
5271
Platinum Group Metals
PLG
$164M
| $48K | ﹤0.01% |
+2,900
| New | +$50.4K |
|
5272
CALL
Shopify
SHOP
$152B
| $48K | ﹤0.01% |
7,000
-3,000
| -30% | -$17.3K |
|
5273
CALL
ProShares Ultra Real Estate
URE
$57.8M
| $48K | ﹤0.01% |
800
-2,000
| -71% | -$117K |
|
|
VRAY
5274
DELISTED
ViewRay, Inc.
VRAY
| $48K | ﹤0.01% |
5,660
+5,549
| +4,999% | +$30.3K |
|
|
CSLT
5275
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $48K | ﹤0.01% |
13,086
+12,347
| +1,671% | +$43.4K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.